Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.
Panelists highlight the importance of early recognition and identification of appropriate candidates for dalbavancin and oritavancin and of ensuring proper follow-up and post-treatment monitoring for patients with acute bacterial skin and skin structure infection.
